Most US and Canadian patients who pursue stem cell treatment end up looking abroad, usually because of price. Before comparing countries, one principle matters more than any of them:
The country is not the safety signal. The clinic is.
Some overseas clinics run rigorous, physician-led programmes with published protocols. Others operate in a particular country precisely because oversight there is lighter than the FDA’s. Both exist in the same city. Judge the individual clinic.
Destination comparison
| Destination | Typical cost | Regulatory picture | Practical notes |
|---|---|---|---|
| United States | $5,000–$25,000+ | FDA active enforcement; most clinic offerings are unapproved | No travel; easier legal recourse |
| Mexico | $3,000–$20,000 | COFEPRIS oversight; enforcement varies | Short flights, established medical tourism corridors |
| Panama | $8,000–$25,000 | Permits some cell therapy under research frameworks | Positioned as premium; English widely spoken |
| Colombia | $5,000–$18,000 | INVIMA oversight | Growing destination |
| Costa Rica | $6,000–$20,000 | Tightened rules after earlier crackdowns | Strong general medical tourism reputation |
| Thailand | $5,000–$25,000 | Thai FDA restricts many uses | Long flight from North America |
| India | $2,000–$15,000 | CDSCO regulation; enforcement inconsistent | Lowest prices, widest quality spread |
What actually protects you
- A named, licensed physician who performs the procedure and whose credentials you can verify independently
- Written disclosure of cell type, source, dose, and viability testing
- A published protocol or registered trial, not a brochure
- Itemised pricing in writing before you travel
- A clear answer to: what happens if there is a complication after I fly home?
- Verifiable independent reviews, not testimonials hosted on the clinic’s own site